冠状动脉左主干及三支病变的血运重建策略SYNTAX研究解析
被引量:5
摘要
高展和乔树宾对SYNTAX研究解读——左主干及3支病变的血运重建策略,是该研究结果发表以来,国内写得最好的一篇评论。文章全面、完整、科学、客观介绍了SYNTAX研究,并对其临床意义进行了实事求是的点评。SYNTAX研究不同于以往比较冠状动脉旁路移植术(CABG)与经皮冠状动脉介入(PCI)的研究,最具有代表性的亮点为:(1)all comers,(2)team dicision making。
出处
《中华心血管病杂志》
CAS
CSCD
北大核心
2010年第1期76-79,共4页
Chinese Journal of Cardiology
参考文献15
-
1Barner HB. Operative treatment of coronary atherosclerosis. Ann Thorac Surg,2008,85 : 1473-1482.
-
2Serruys PW, Kutryk MJB, Ong ATL. Coronary-artery stents. N Engl J Med, 2006,354:483-495.
-
3Daemen J, Boersma E, Flather M, et al. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta analysis with 5-year patient-level data from the ARTS, ERACI-Ⅱ, MASS-Ⅱ, and SoS trials. Circulation,2008, 118:1146-1154.
-
4Booth J, Clayton T, Pepper J, et al. Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with muhivessel coronary artery disease: six'year follow-up from the Stent or Surgery Trial (SoS). Circulation ,2008,118:381-388.
-
5Harman EL, Wu C, Walford G, et al. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med ,2008,358:331-341.
-
6Brener SJ, Galla JM, Bryant R 3rd, et al. Comparison of pereutaneous versus surgical revascularization of severe unprotected left main coronary stenosis in matched patients. Am J Cardiol, 2008,101 : 169-172.
-
7Buszman PE, Kiesz SR, Bochenek A, et al. Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization. J Am Coll Cardiol,2008 ,51:538-545.
-
8Chieffo A, Morici N, Maisano F, et al. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience. Circulation ,2006,113:2542-2547.
-
9Herz I, Moshkovitz Y, Loberman D, et al. Drug-eluting stents versus bilateral internal thoracic grafting for multivessel coronary disease. Ann Thorac Surg,2005 ,80 :2086-2090.
-
10Lee MS, Kapoor N, Jamal F, et al. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drugeluting stents for unprotected left main coronary artery disease. J Am Coll Cardiol, 2006, 47:864-870.
同被引文献39
-
1王小艳.急性冠脉综合征后6个月死亡和心肌梗死的预测:前瞻性的多国观察性研究(GRACE)[J].中国处方药,2006(11):25-26. 被引量:138
-
2吴清玉,许建屏,高长青,万峰,孟强,吴若彬,肖明弟,肖锋,王东进,李洪银,李雷.冠状动脉旁路移植术技术指南[J].中华外科杂志,2006,44(22):1517-1524. 被引量:52
-
3韩雅玲,王守力,荆全民,刘海伟,马颖艳,王祖禄,王冬梅,栾波,王耿.冠状动脉支架术治疗416例择期无保护左冠状动脉主干病变的2年随访[J].中华医学杂志,2007,87(16):1109-1112. 被引量:3
-
4陈劢,卢辉,茶春喜,姚建平,杜晓强,艾克拜尔.Firebird冠状动脉内支架的临床应用[J].实用诊断与治疗杂志,2007,21(8):609-610. 被引量:4
-
5Eagle KA,Guyton RA,Davidoff R,et al.ACC/AHA 2004 guideline update for coronary artery bypass graft surgery:a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).Circulation,2004,110:e340-e437.
-
6Smith SC,Feldman TE,Hirshfeld JW,et al.ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention).Circulation 2006,113:e166-e286.
-
7Schouten O,Bax JJ,Dunkelgrun M,et al.Statins for theprevention of perioperative cardiovascular complications in vascular surgery.J Vasc Surg,2006,44:419-424.
-
8Karthikeyan G,Bhargava B.Managing patients undergoing noncardiac surgery:need to shift emphasis from risk stratification to risk modification.Heart,2006,92:17-20.
-
9Hindler K,Shaw AD,Samuels J,et al.Improved postoperative outcomes associated with preoperative statin therapy.Anesthesiology,2006,105:1260-1272.
-
10Biccard BM,Sear JW,Foex P.Statin therapy:a potentially useful perioperative intervention in patients with cardiovascular disease.Anaesthesia,2005,60:1106-1114.
引证文献5
-
1陈伟,张健群,甘辉立,王胜洵,孔睛宇,郑斯宏,伯平,黄国晖.左主干病变冠脉搭桥患者围术期及中长期临床效果分析[J].中华医学杂志,2011,91(15):1016-1021.
-
2郭远林,颜红兵.急性冠状动脉综合征风险评估方法学进展[J].心血管病学进展,2015,36(6):681-686. 被引量:4
-
3周明阳,张健群,毛斌,伯平,曹向戎.冠状动脉旁路移植术患者死亡相关因素分析[J].中国医药,2017,12(3):343-346. 被引量:5
-
4黄平,王晓冬,李兴,董秀红,赵学伟,王伟.2型糖尿病合并冠状动脉三支病变患者的临床特点及介入治疗远期预后[J].中国老年学杂志,2017,37(13):3211-3213. 被引量:1
-
5韩雅玲.复杂高危冠状动脉病变介入治疗的现状与挑战[J].中华心血管病杂志,2021,49(8):750-753. 被引量:4
二级引证文献14
-
1向林军,肖涛,王莎,张小红,郭美英,王晓琳,张月娟.两种评分系统对急性冠脉综合征患者不良事件预测价值比较[J].中华急危重症护理杂志,2020,1(2):108-112. 被引量:1
-
2毛森,赵鲁平,赵晓莉,王江涛,胡军利,王少春.应用左室压力-应变环评价不同程度冠状动脉狭窄患者心肌做功的定量研究[J].中国医师杂志,2022,24(10):1515-1520. 被引量:2
-
3吴秋香,阮爱兵,胡保奎,张丙雨.NSTE-ACS患者GRACE评分和NLR与冠状动脉病变的关系[J].心脏杂志,2017,29(4):416-419. 被引量:2
-
4李扬,董然,芮宏亮,刘韬帅,郑居兵,华琨,赵洋,张魁,黄琦.合并终末期肾病的冠状动脉粥样硬化性心脏病患者行冠状动脉旁路移植术临床疗效分析[J].中国医药,2018,13(6):833-836. 被引量:3
-
5张乐影.曲美他嗪联合低分子肝素治疗不稳定型心绞痛的临床效果[J].临床研究,2018,26(12):97-99. 被引量:4
-
6解鑫隆,徐朝军,项宇,倪广生.芪参益气滴丸对冠状动脉旁路移植术后病人心室重构及心功能的影响[J].中西医结合心脑血管病杂志,2019,17(8):1137-1141. 被引量:5
-
7王素妍,刘海霞,蔡填,肖正华.PCI治疗对于2型糖尿病合并冠心病患者的疗效及对心功能的影响[J].心血管康复医学杂志,2020,29(1):85-90. 被引量:8
-
8周明阳,杨秀滨,华琨,毛斌,张良,孙东.高龄冠状动脉左主干狭窄病变患者的外科治疗[J].中华老年医学杂志,2020,39(1):47-50. 被引量:4
-
9王丽,赵筱雯.冠状动脉旁路移植术后使用重组活化凝血因子Ⅶ的疗效分析[J].血栓与止血学,2020,26(1):1-3. 被引量:1
-
10王艳敏,张悟麟,李桂梅.冠状动脉粥样硬化性心脏病患者CABG术后早期死亡预测模型的建立及应用[J].临床心身疾病杂志,2020,26(5):46-50. 被引量:3
-
1李裕舒,黎明.左主干及3支病变的的血运重建策略——SYNTAX研究解读[J].临床心血管病杂志,2009,25(2):83-84. 被引量:6
-
2吕树铮.冠心病介入治疗新进展[J].中华老年心脑血管病杂志,2007,9(3):145-148. 被引量:12
-
3王智谦,韩雅君.冠脉多支血管病变患者的危险分层与治疗策略[J].内蒙古医学杂志,2013,45(4):463-465. 被引量:1
-
4韩雅玲.完全性或不完全性血运重建临床疗效的评价[J].中国循环杂志,2010,25(6):403-404. 被引量:4
-
5李为民,李悦.AFFIRM研究解析[J].中国心脏起搏与心电生理杂志,2004(z1):60-61. 被引量:1
-
6金彦彦,马长生,康俊萍,聂绍平,张崟,吕强,刘晓惠,吴学思,胡荣.左心室射血分数≤40%冠心病患者不同血运重建策略的比较[J].中国综合临床,2009,25(2):116-119. 被引量:1
-
7孙艺红,胡大一.FREEDOM研究解析[J].中华心血管病杂志,2013,41(3):260-261.
-
8李长龙,邹剑杰.冠心病合并代谢综合征冠脉特征及对血运重建的影响[J].西部医学,2007,19(5):808-810. 被引量:1
-
9朱家赫,于彤彤,孙兆青.完全血运重建策略对老年急性ST段抬高型心肌梗死合并多支血管病变患者预后的影响[J].中国医科大学学报,2017,46(3):227-231. 被引量:19
-
10袁晋青,马元良.ST段抬高型心肌梗死伴多支冠状动脉病变患者的介入治疗策略[J].中国循环杂志,2016,31(10):954-956. 被引量:10